tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Holding GANX?
Track your performance easily

Gain Therapeutics (GANX) Financial Statements

248 Followers

Gain Therapeutics Financial Overview

Gain Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.107; its P/E ratio is -1.41; Gain Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -4.58M$ -8.23M$ -4.11M$ -4.41M$ -4.89M
EBITDA$ -4.56M$ -8.21M$ -4.09M$ -4.38M$ -4.86M
Net Income Common Stockholders$ -4.49M$ -8.14M$ -4.01M$ -4.72M$ -4.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.05M$ 16.94M$ 12.66M$ 16.79M$ 12.23M
Total Assets$ 14.37M$ 19.20M$ 14.58M$ 18.61M$ 14.10M
Total Debt$ 769.41K$ 807.57K$ 889.62K$ 1.03M$ 1.04M
Net Debt$ -11.28M$ -16.13M$ -11.77M$ -15.77M$ -11.19M
Total Liabilities$ 5.46M$ -4.79M$ 5.94M$ 6.03M$ 6.77M
Stockholders Equity$ 8.91M$ 23.94M$ 8.64M$ 12.58M$ 7.33M
Cash Flow-
Free Cash Flow$ -6.08M$ -5.78M$ -3.59M$ -5.66M$ -3.97M
Operating Cash Flow$ -6.08M$ -5.76M$ -3.59M$ -5.66M$ -3.97M
Investing Cash Flow$ -1.00$ 2.00M$ 3.02M$ 3.14M$ 1.93M
Financing Cash Flow$ 808.68K$ 10.04M$ -145.80K$ 9.56M$ 134.47K
Currency in USD

Gain Therapeutics Earnings and Revenue History

Gain Therapeutics Debt to Assets

Gain Therapeutics Cash Flow

Gain Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis